Global response to non-communicable disease
暂无分享,去创建一个
D. Xavier | D. Prabhakaran | Lijing L. Yan | A. Rubinstein | S. Kimaiyo | M. Ramírez-Zea | Yangfeng Wu | A. Cravioto | L. Niessen | N. Levitt | T. Koehlmoos | Richard Smith | M. T. Cerqueira | H. Ghannem | Jaime Miranda | N. Dianis
[1] D. Grobbee,et al. An International Randomised Placebo-Controlled Trial of a Four-Component Combination Pill (“Polypill”) in People with Raised Cardiovascular Risk , 2011, PloS one.
[2] Joan K. Morris,et al. Screening for Future Cardiovascular Disease Using Age Alone Compared with Multiple Risk Factors and Age , 2011, BDJ.
[3] Richard Smith. Health ministers pledge to tackle non-communicable diseases with global action , 2011, BMJ : British Medical Journal.
[4] Martin McKee,et al. Priority actions for the non-communicable disease crisis , 2011, The Lancet.
[5] T. Macdonald. Preventing Chronic Diseases: A Vital Investment , 2006 .
[6] N J Wald,et al. A strategy to reduce cardiovascular disease by more than 80% , 2003, BMJ : British Medical Journal.
[7] W. J. Elliott,et al. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial , 2010 .
[8] G. Carrin,et al. WHO The world health report - health systems financing: the path to universal coverage. , 2010 .
[9] R. Cunningham. Where have all the donors gone? , 1980, Trustee : the journal for hospital governing boards.